Announcements Trials
Browse Landscape

Phase

Phase 3 3Phase 4 1

Status

Completed 6Unknown 4Terminated 2Withdrawn 1Active not recruiting 1

Sponsor Class

OTHER 3NIH 1

Study Type

Interventional 4

Sponsor

Cancer Type

Lymphoid 4

Conditions

Hodgkin Disease 4Lymphoma 1

Interventions

Cisplatin 504Cyclophosphamide 353Radiotherapy 349Carboplatin 347Capecitabine 328Oxaliplatin 319Paclitaxel 316Gemcitabine 315Docetaxel 308Fluorouracil 281apatinib 240Drug Therapy 239Bevacizumab 224camrelizumab 212Etoposide 199Irinotecan 176Doxorubicin 174Dexamethasone 159Leucovorin 158sintilimab 140Pemetrexed 136Cytarabine 136pembrolizumab 135anlotinib 135toripalimab 124S 1 (combination) 119Neoadjuvant Therapy 119Vincristine 118Rituximab 114Radiosurgery 113

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Unknown × Interventional × ABVD protocol × Clear all
NCT00736320 2020-11-04

HD16

University of Cologne

Phase 3 Unknown
1,150 enrolled
Lymphoid

Hodgkin Disease

NCT00041210 2013-09-20

Combination Chemotherapy in Treating Patients With Previously Untreated Advanced Hodgkin's Lymphoma

National Cancer Institute (NCI)

Phase 3 Unknown
850 enrolled
Lymphoid

Hodgkin Disease, Lymphoma

NCT00816959 2011-07-20

Study Evaluating the Effect of R-mabHDI in Lymphocytic Predominant Hodgkin's Lymphoma

American Scitech International

Phase 3 Unknown
1,200 enrolled
Lymphoid

Hodgkin Disease

NCT00188149 2005-12-29

Optimization of the Primary Therapy for Patients With Hodgkin's Disease and Evaluation of PET

University Hospital Carl Gustav Carus

Phase 4 Unknown
300 enrolled
Lymphoid

Hodgkin Disease

Data powered by HemOnc (CC BY 4.0) Colophon âš¡